Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Indaba Capital Management Considerably Reduces Stake In JGWPT Holdings Inc (JGW)

Indaba Capital Management, run by Derek C. Schrier, has reported a decrease in its holding of JGWPT Holdings Inc (NYSE:JGW). Schrier has more than halved the fund’s investment in this stock, leaving it with 433,372 shares, according to a recent filing with the Securities and Exchange Commission. This gives Indaba Capital Management control over 3.36% of the company’s common stock.

JGWPT website logo x288

JGWPT Holdings Inc (NYSE:JGW) has also caught the attention of Sahm Adrangi, who has invested 6.22% of his equity portfolio in this company. His fund, Kerrisdale Capital, has reported ownership of 693,600 shares, up 204% during the first quarter of 2014. Geoffrey Raynor is also keeping an eye on this company, with his fund, Q Investments (Specter Holdings), holding approximately 412,000 shares. Ken Griffin, on the other hand, has trimmed his fund’s exposure to JGWPT Holdings Inc (NYSE:JGW) during the first quarter. Citadel Investment Group reportedly holds approximately 529,500 shares, down 18% during the first three months of this year.

Disclosure: none.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!